Appointment of Joint Broker

RNS Number : 2062G

Zotefoams PLC

14 November 2022

 

Zotefoams plc

("Zotefoams" or the "Group")

Appointment of Joint Broker

Zotefoams plc, the UK-headquartered specialist in advanced cellular materials, is pleased to announce the appointment of Singer Capital Markets as the Group's joint broker, alongside Peel Hunt, with immediate effect.

- Ends -

Enquiries:

Zotefoams plc	[phone]
David Stirling, Group CEO Gary McGrath, Group CFO
IFC Advisory	[phone]
Graham Herring Tim Metcalfe Zach Cohen

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE^® polyolefin and ZOTEK^® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT^® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce^® mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA, Stilling, Denmark (microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE^®, ZOTEK^®, ReZorce^® and T-FIT^® are registered trademarks of Zotefoams plc.

 

END

 

 

APPUASNRUSUAAAA